INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 171 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $166,896 | -15.7% | 13,492 | -5.0% | 0.00% | 0.0% |
| Q3 2022 | $198,000 | -82.7% | 14,200 | -82.8% | 0.00% | -83.3% |
| Q2 2022 | $1,143,000 | +72.1% | 82,749 | +102.8% | 0.01% | +100.0% |
| Q1 2022 | $664,000 | -33.5% | 40,808 | -33.5% | 0.00% | 0.0% |
| Q4 2021 | $999,000 | -0.3% | 61,328 | -9.1% | 0.00% | 0.0% |
| Q3 2021 | $1,002,000 | +53.9% | 67,504 | +107.0% | 0.00% | +50.0% |
| Q2 2021 | $651,000 | -58.7% | 32,616 | -52.2% | 0.00% | -77.8% |
| Q1 2021 | $1,576,000 | +107.6% | 68,302 | +273.2% | 0.01% | -10.0% |
| Q3 2020 | $759,000 | +23.2% | 18,300 | +42.2% | 0.01% | 0.0% |
| Q2 2020 | $616,000 | -19.6% | 12,867 | +5.8% | 0.01% | -50.0% |
| Q1 2020 | $766,000 | -35.8% | 12,164 | -32.3% | 0.02% | +81.8% |
| Q3 2019 | $1,193,000 | +247.8% | 17,979 | +428.9% | 0.01% | +175.0% |
| Q4 2018 | $343,000 | -17.3% | 3,399 | +3.6% | 0.00% | -20.0% |
| Q3 2018 | $415,000 | -88.6% | 3,281 | -94.7% | 0.01% | -92.2% |
| Q4 2017 | $3,648,000 | -2.4% | 62,445 | +102.3% | 0.06% | -13.5% |
| Q2 2017 | $3,737,000 | +400.9% | 30,865 | +367.7% | 0.07% | +252.4% |
| Q1 2017 | $746,000 | +32.0% | 6,600 | +26.9% | 0.02% | -8.7% |
| Q4 2016 | $565,000 | +49.1% | 5,200 | +126.1% | 0.02% | -8.0% |
| Q3 2016 | $379,000 | +1.6% | 2,300 | -20.7% | 0.02% | -13.8% |
| Q1 2016 | $373,000 | – | 2,900 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 635,300 | $53,308,000 | 10.69% |
| Senvest Management, LLC | 976,127 | $81,907,000 | 5.65% |
| Melqart Asset Management (UK) Ltd | 390,600 | $32,775,000 | 2.80% |
| Asymmetry Capital Management, L.P. | 25,918 | $2,175,000 | 2.14% |
| Elk Creek Partners, LLC | 386,397 | $32,423,000 | 1.78% |
| BB BIOTECH AG | 545,719 | $45,791,000 | 1.32% |
| ALTRINSIC GLOBAL ADVISORS LLC | 383,166 | $32,151,000 | 1.27% |
| DLD Asset Management, LP | 129,000 | $10,824,000 | 0.82% |
| Opus Point Partners Management, LLC | 3,998 | $335,000 | 0.73% |
| Virtus ETF Advisers LLC | 8,970 | $753,000 | 0.67% |